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Background and Objective: Fractional photothermoly-
sis (FP) is a new concept using arrays of microscopic
thermal damage patterns to stimulate a therapeutic
response. We analyzed epidermal and dermal response to
FP with the aim of correlating histological and clinical
response.
StudyDesign/Materials andMethods: Twelve subjects
received a single treatment with a prototype diode laser
emitting at a wavelength of 1,500 nm, delivering 5 mJ per
microscopic treatment zone (MTZ), and a density of
1,600 MTZs/cm2 on the forearm. Biopsies were procured
over a period of 3 months. The biopsies were analyzed by
two blinded dermatopathologists using hematoxylin and
eosin (Hematoxylin and Eosin Stain), Elastica von Gieson,
nitro-blue-tetrazolium-chloride (NBTC) viability, and
immunohistochemistry stains. Furthermore, the treat-
ment sites were evaluated in vivo by confocal microscopy.
Results and Discussion: Twenty-four hours after frac-
tional photothermolysis, the continuity of the epidermal
basal cell layer is restored. Complete epidermal regenera-
tion is obtained 7 days after the treatment. Microscopic
epidermal necrotic debris (MENDs) are seen as early as
1 day after FP. MENDs contain melanin pigment, and are
shed from the epidermis within 7 days. Evidence of
increased collagen III production is shown with immuno-
histochemistry (IHC) staining 7 days after FP. IHC for heat
shock protein 70 (HSP 70) shows the expression of HSP
1 day after FP, and IHC for alpha smooth muscle actin
shows thepresence ofmyofibroblasts 7 days afterFP.These
findings are concordant with the induction of a wound
healing response by FP. There is no evidence of residual
dermal fibrosis 3 months after treatment.
Conclusion: A single treatment with fractional photo-
thermolysis induces a wound healing response in the
dermis. A mechanism for the precise removal of epidermal
melanin is described, in which MENDs act as a melanin
shuttle. Lasers Surg. Med. 38:142–149, 2006.
 2006 Wiley-Liss, Inc.
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INTRODUCTION
Non-ablative dermal remodeling and ablative skin
resurfacing are currently well-established treatment mod-
alities for the repair of photoaged skin. Ablative skin
resurfacing with CO2 or Er:YAG laser removes the entire
epidermis of the treatment area. This is generally con-
sidered to be the most effective laser treatment option for
the repair of photodamaged tissue, but patients sometimes
experience significant side effects after the treatment.
Especially long lasting pigmentary changes, infection, and
scarring are unacceptable for many patients [1,2]. Non-
ablative laser and intense-pulse-light systems are cur-
rently used as an alternative to tighten the skin without
harming the epidermis. In this technique, controlled
dermal heating without epidermal damage is achieved by
combining the laser or intense-pulsed-light treatment with
simultaneous skin surface cooling. The selective thermal
damage of the dermis is followed by wound healing
response of the damaged tissue ultimately leading to new
collagen formation. The absence of epidermal damage
decreases the severity and amount of side effects associated
with the treatment. However, the major disadvantage of
this technique is the limited efficacy compared to ablative
laser skin resurfacing [3–5].
Fractional photothermolysis (FP) was recently intro-
duced by Manstein et al. [6] as a new concept for laser skin
rejuvenation to address the drawbacks of both, ablative
skin resurfacing with its significant side effects and non-
ablative dermal remodeling with its limited efficacy. In FP,
a near infrared 1,500-nm laser light, which is mainly
absorbed by aqueous tissue, creates a dense pattern of epi-
dermal and dermal microscopic thermal wounds (referred
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to as Microthermal zones (MTZ)) and characteristically
spares the tissue that surrounds each MTZ. Typically a
density of 1,000–2,000 MTZs per square centimeter is
achieved.
Thepurpose of this study is to investigate ifFP, creatinga
unique pattern of microscopic thermal lesions, still induces
awoundhealing response in thehumanskin. Furthermore,
we want to examine the effect of this new treatment
modality on the formation of new collagen in the dermis.
Additionally exploring the effect of FP on elastic fibers is of
great interest since solar elastosis is one of the most
prominent histological findings in dermatoheliosis. To
answer those questions, we investigated the pathophysio-
logical mechanisms that are involved in FP using common
histological stainingmethods, immunohistochemistry, and
in vivo confocal microscopy.
MATERIALS AND METHODS
Study Subjects
Twelve healthy volunteers with no known history of
keloid formation, isotretinoin use within the last 6months,
current systemic infection, or previous laser treatment of
the area to be treated were enrolled in this study. The
subjects had multiple Fitzpatrick skin types (II–VI), and
ranged between 24 and 64 years of age. Test sites of 8
8 mm2 in size were placed at the inner forearm of each
subject and were mapped with four microtattoos at the
corners of each site.No cooling or analgesiawasused before
the exposure.
To understand the immediate and long-term skin
response to FP biopsies were performed at 1 hour and 1,
3, 5, and 7 days and 3 months after the exposure. The time
points of biopsies were randomly assigned to each subject.
Subjectshadamaximumof fourbiopsies each includingone
control biopsy; control biopsies were taken at 3 months
after exposure from unexposed areas that were adjacent to
the treated sites.
Laser
A laser prototype device (Reliant Technologies, Inc., Palo
Alto, CA), which emits a wavelength of 1,500 nm, was used
to provide a distinct and well-defined pattern of micro-
exposures at adistance of 250microns fromthe center of the
individual MTZs. This correlates with 1,600 lesions per
square centimeter. A constant energy of 5 mJ perMTZwas
used.
Confocal Microscopy
A commercially available confocal microscope (Viva-
scope10001, Lucid-Tech, Inc., Henrietta, NY) was
employed to image some of the laser-treated sites. A
detailed description of this device has been published
elsewhere [7]. The treatment sites were analyzed continu-
ously for up to 6 hours after exposure, and a systematic
horizontal mapping was obtained. Four to six images were
captured in axial sections of the stratum corneum,
epidermis, and up to the upper reticular dermis. The
images were then individually evaluated.
Histology
The excised skin was fixed in 10% formalin and
embedded in paraffin. Three-micrometer thick sections
were stained with hematoxylin and eosin (H&E),
and Elastica von Gieson stains were prepared for histologi-
cal analysis. Samples intended for NBTC viability stain-
ing were processed separately for frozen sections.
NBTC staining was performed as described by Chung
et al. [8]
Immunohistological (IHC) staining was performed to
detect proliferating cells using proliferating cell nuclear
antigen (PCNA, BioGenex, San Ramon, CA), myofibro-
blasts using alpha-smoothmuscle actin (a-SMA,BioGenex,
San Ramon, CA), new collagen formation using Collagen
type III (BioGenex, SanRamon, CA), and physical stress on
tissue using heat shock protein 70 (HSP 70, BioGenex, San
Ramon, CA).
Immunohistochemistry staining was performed accord-
ing to the standard routine techniques as supplied by the
manufacturer (BioGenex, San Ramon, CA).
Two pathologists who are experienced in the area of skin
pathology and cutaneous laser treatment analyzed the
sections independently.
RESULTS
Confocal Microscopy
In vivo confocal microscopy reveals a complete loss of
dermal reflection in the MTZs immediately after FP.
However, there is an increase of reflection throughout the
epidermal portion of the MTZs. There is evidence of an
increase in reflectance of the stratum corneum after the
treatment. The dermo-epidermal junction reveals a sub-
epidermal reflection loss immediately after the exposure.
The size of the area of subepidermal reflection loss
increases over the next 6 hours (Fig. 1).
Fig. 1. Hour 6 after FP—in vivo confocal microscopy. A
horizontal cut-through dermo-epidermal junction shows areas
of reflection loss (white stars) in the MTZ (black outline).
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One Hour After FP (Hematoxylin and Eosin Stain)
Biopsies that were taken one hour after FP reveal
an intact stratum corneum with a normal basket-wave
appearance and no evidence of structural alterations. A
well-defined underlying column of epidermal and dermal
thermal damage is noted, and is referred to as the
Microthermal zone (MTZ).
Theepidermal damage is predominantly in the lowerhalf
of the epidermis, which leads to disruption of the dermo-
epidermal junction and the beginning of the formation of
sub-epidermal clefting. No inflammatory infiltrate is yet
seen in the region surrounding the MTZs (Fig. 2a). Vessels
that are located within the individual MTZs appear to be
thermally coagulated without concomitant hemorrhage
into the surrounding tissue (Fig. 2b).
One Day After FP (Hematoxylin and Eosin Stain)
Although the dermal part of the MTZ appears un-
changed, there are marked morphological changes within
the epidermis.
Day 1 marks the formation of microscopic epidermal
necrotic debris (MENDs), which is thought to represent the
elimination of the thermally damaged keratinocytes
through the migration of the viable keratinocytes that are
present at themargins of the wound. TheMENDs reside in
the epidermis in a sub-granular location, and contain a
substantial amount of pigment. Fontana Masson stain
confirms the presence of melanin pigment within the
MENDs in higher density than in the in the surrounding
epidermis. The basal cell layer that underlies the MENDs
appears to be melanin deprived but continuous. Scattered
dyskeratotic cells in the epidermis are seen in close ap-
proximation to the MTZs and in the surrounding MENDs.
Subepidermal clefting is now more pronounced in the
area of the MTZ and overlies a well-defined zone of
homogenized collagen. A subtle inflammatory infiltrate is
present predominantly around thevascular structures that
surround the MTZs (Fig. 3).
Three Days After FP (Hematoxylin and Eosin Stain)
The MENDs have exited the epidermis and are now
sandwiched between the epidermis and the stratum
corneum. The epidermis demonstrates dyskeratotic cells
and spongiosis. The subepidermal clefting is regressing,
and only small residual clefts are observed. A well-defined
cone ofhomogenized collagen can still be seen in thedermis.
Fig. 2. a: Hour 1 after FP (200 H&E). Microthermal zones
(MTZ, black outline) with columns of altered collagen (black
arrow) can be distinguished. The entire stratum corneum
remains intact even above the epidermal MTZs. There is no
inflammatory infiltrate around the dermalMTZs yet.b:Hour 1
after FP (200 H&E) vessels in the MTZs are thermally
destroyed (white arrows).
Fig. 3. Day1afterFP (200H&E).MTZsare outlined inblack.
Microscopic epidermal necrotic debris (MENDs; black arrows)
represents the elimination of thermally damaged keratino-
cytes.MENDs are loadedwithmelanin. Subepidermal clefting
is evident from 1 hour after FP and lasts up to 5 days (stars).
The dermal part of the MTZs appears unchanged from day 1,
and shows thermally altered collagen and a lack of nuclear
staining. Subtle perivascular inflammatory infiltrate begins to
form in the dermis (white arrow).
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Five Days After FP (Hematoxylin and Eosin Stain)
The MENDs are now floating within the stratum
corneum. A few dyskeratotic keratinocytes and minimal
spongiosis can still be observed in theepidermis.There isno
evidence of residual subepidermal clefting. Zones of
homogenized dermis are still present, and are associated
with minimal—predominantly lymphocytic—perivascular
dermal inflammation.
Seven Days After FP (Hematoxylin and Eosin Stain)
TheMENDs are either intracorneal or have already shed
off. The epidermis is otherwise normal in appearance, and
shows a well-developed architecture with normal to
increased epidermal thickness and a normal rete ridge
pattern with no dyskeratosis, spongiosis, or clefting.
The dermis still reveals cones of thermally altered
collagen. There is a regressing inflammatory infiltrate
with occasional foci of new vascular formation surrounding
and infiltrating the MTZs (Fig. 4).
Three Months After FP (Hematoxylin and
Eosin Stain)
There is noevidence of dermalfibrosis or residual cones of
altered collagen. Furthermore, there is no evidence of
residual inflammatory infiltrate. The MTZs can no longer
be seen with standard H&E staining.
Elastica Von Gieson
There is no noted difference in the quantity or the
arrangement of elastic fibers, as demonstrated with von
Gieson stain, at any given point in the study. The elastic
fibers retain their characteristic candelabra structure after
FP (Fig. 5).
Nitro-Blue-Tetrazolium Chloride (NBTC)
Viability Stain
The NBTC stain reveals a loss of viability in the
epidermis and the dermis at 1 hour after FP. One day after
the exposure the dermis shows a continuous layer of viable
cells overlying dermal zones of loss of viability (Fig. 6).
These zones become less and less well defined in the
biopsies form Day 3 to Day 7. Three months after FP, a
continuous viability staining of both the epidermis and the
dermis can be found.
Please note that the stratum corneum never stains
positive for NTBC in normal epidermis.
Fig. 4. Day 7 after FP (200 H&E). MENDs are intracorneal
or have shed off (black arrow). The epidermis is free of
dyskeratosis and spongiosis. There is no evidence of residual
clefting in the dermo-epidermal junction. The dermal MTZs
(black outline) still show cones of thermally altered collagen,
but they are less well defined.
Fig. 5. Day 7 after FP (200—Elastica von Gieson). The
regular candelabra arrangement of elastic fibers persists at all
times after FP (white arrow). MTZs are outlined in black.
Fig. 6. Day 1 after FP (200—NBTC viability stain). MTZs
(black outline) consist of viable epidermis overlying dermal
cones with complete loss of viability.
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Heat Shock Protein (HSP) 70
There is no evidence of increased HSP 70 expression
1 hour after FP. An increase in HSP 70 staining is detected
only on the first day after FP exposure. Biopsies performed
three days and later after FP did not show any evidence of
increased HSP 70 expression.
In the biopsies form one day after FP there is a strong
increase in HSP 70 concentration in the epidermis,
particularly within the areas that underlie the MENDs.
There is also a complete loss of HSP 70 expression in the
dermal MTZs themselves, but a strong increase in expres-
sion in the tissue that surrounds the MTZs (Fig. 7).
Collagen III
Immunohistochemistry studies show a complete absence
of staining for collagen III one hour after the treatment
inside the dermal MTZs, which suggests the thermal
alteration of collagen III. Collagen III staining gradually
increases from the first to the seventh day after FP
exposure. It is more prominent in the dermis that
surrounds theMTZs, with the highest intensity being seen
in the dermis that underlies the MTZs (Fig. 8).
There is no evidence of altered dermal collagen III
staining 3 months after FP.
Proliferating Cell Nuclear Antigen (PCNA)
An increase in epidermal PCNA expression is noted up to
9 days after FP. There is no difference in the epidermal
expression of PCNA between the treated sites and the
control sites 3months after FP. No difference in the dermal
expression of PCNA can be detected at any time after FP.
Alpha-Smooth Muscle Actin
The foci of new vessel formation in the dermis surround-
ing theMTZs are demonstrated by a-SMAstain 7 days after
FP. These foci partially infiltrate the dermal MTZs.
Fig. 7. Day 1 after FP (200—immunohistochemistry forHSP
70 with underlying NTBC viability stain). The overall HSP 70
expression is increased in the dermis and epidermis compared
to 1 hour and 3 days after FP. The areas underlying the
MENDs in the epidermis and surrounding the MTZs in the
dermis show themost pronounced expression (black arrows). A
decrease in HSP 70 expression is seen in the area surrounding
the epidermal MTZs (white arrows). There is a complete
absence of HSP 70 expression in the dermal MTZs (black
outline). Compared to one day after FP, there is no increase in
HSP 70 expression 1 hour or 3 days after FP.
Fig. 8. Day 7 after FP (100—immunohistochemistry for
collagen III with underlying NTBC viability stain). Collagen
III expression increases in the periphery of the MTZs,
particularly below the MTZs (black arrows). Collagen III
expression is absent in the dermal MTZs (black outline).
Fig. 9. Day 7 after FP (400—immunohistochemistry for
alpha smooth muscle actin with underlying NTBC viability
stain). Myofibroblasts (actin-containing fibroblasts) can be
seen on day 7 after FP (black arrow). There is evidence of
increased vasculature around the MTZs (white arrow).
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Furthermore, myofibroblasts, which are fibroblasts
that contain actin, can also be seen at 7 days after FP
(Fig. 9).
Miscellaneous
Occasional dermalmelanophageswere detected 3months
after FP in one subject with Fitzpatrick skin type VI.
DISCUSSION
FP was recently introduced as a new concept of laser-
tissue interaction by Manstein et al. [6]. In this study, we
histologically investigated the in vivo effects of this new
treatment modality on human skin. The laser-treated sites
were evaluated with standard H&E stains; special stains,
such as Elastica von Gieson; NTBC viability; IHC studies;
and confocal microscopy.
The confocal microscopy study affirmed that the sub-
epidermal clefting seen in the histological analysis does
correlate with a subepidermal reflection loss in vivo. Hence
the clefting an in vivophenomenonanddoesnot represent a
histological preparation artifact. Furthermore, confocal
microscopy reveals a complete loss of dermal reflection in
theMTZs immediately afterFP.This is basedmost likely on
the thermal denaturation and the resulting change of
optical properties of dermal collagen [7,9,10].
Probably the most prominent epidermal effect that is
induced by FP is the formation of MENDs and their timed
migration within the epidermal layers. The process of
elimination of necrotic epidermal cells forms the MENDs,
and they are noted as early as 24 hours after the FP
treatment (Fig. 3). In how far dermal necrotic debris is part
of the MENDs cannot be determined at this point. The
MENDs are located in the epidermis just below the
granular cell layer at day one, and thus correlates clinically
with the onset of bronzing, as noted by patients at day one,
that is secondary to the high melanin content of the
MENDs. At day 3, the MENDs have migrated through
the epidermis and lie just below the stratum corneum,
which correlates with the clinical onset of flaking that is
generally noticed by patients at day three. Flaking occurs
due to the elimination of the MENDs from the stratum
corneum, and becomes more prominent on days 5–7 after
FP due to the ease of elimination of the MENDs when they
are located in the middle and superficial layers of the
stratum corneum (Fig. 4). MENDs have rich melanin
content as seen in the H&E stain (Fig. 3). Furthermore,
the underlying newly formed basal cell layer exhibits a
decrease in melanin content, and it appears that the
melanin pigment that was previously present in the basal
cell layer isnowapart of theMENDs,whichare loadedwith
melanin, and is transported by the MENDs through the
epidermis. Thus, the MENDs act as ‘‘melanin shuttle’’
(Fig. 3). The upward movement of the MENDs may be
the result of the rapid migration of keratinocytes from the
borders of the epidermal MTZs. This process leads to
the elimination of melanin from the epidermis and is
most likely the reason for the lightening of lentigines and
melasma after FP treatment.
Due to the remaining undamaged stratum corneum and
the multiple layers of necrotic keratinocytes above the
dermis (Figs. 2a and 3), it is expected that the epidermal
barrier function remains intact after FP. We would like to
remark that this is the finding for settings used in this
particular study. We believe that a perforation of the
stratum corneum can be obtained with higher energies
than used in this study. Twenty-four hours after FP,
healthy keratinocytes have replaced the thermally
damaged keratinocytes in the epidermis (Fig. 6), which
closes an areawith a lack of viability stain that was evident
1 hour after FP. These two findings together explain the
minimal risk of infection, oozing, or macroscopic crusting
with this new treatment modality.
Day 7 after FP marks the apparently complete normal-
ization of the epidermis with no residual dyskeratosis,
spongiosis, or subepidermal clefting (Fig. 4), which indi-
cates complete epidermal healing. We, therefore, suggest a
treatment interval of at least 1 week for common applica-
tions of FP to allow enough time for the adequate
regeneration of the epidermis. Shorter intervals may be
warranted for indications outside of the current routine use
of FP.
Collagen remodeling and formation after non-ablative
and ablative resurfacing is thought to be a primary
component in the reduction of rhytides and the improve-
ment of skin texture. Some authors report evidence of new
collagen formation as detected by the evaluation of regular
H&E stain or orcein stain after non-ablative resurfacing
[11–14]. After consultation with several independent
dermatopathologists, we are hesitant to draw this conclu-
sion from the evaluation of the collagen alignment in the
H&Estained tissue sections alone.The total absence of IHC
staining for collagen III inside the dermal MTZs 1 hour
after the treatment corresponds to the thermal denatura-
tion of collagen III. Subsequently, collagen III staining
increases around and especially below the MTZs up to
7 days after exposure (Fig. 7). There is no evidence of
decreased collagen III staining throughout the dermis
3 months after exposure, which shows that thermally
damaged collagen inside the MTZ is completely replaced
with new collagen after 3 months. These findings suggest
the formation of new collagen in the dermis in and around
the MTZ, which is an expected wound healing response.
Sublethal thermal stress to human tissue in vivo leads to
the expression of HSPs. HSP 70 belongs to a group of
proteins called chaperons preserving the cell integrity in
sublethally damaged cells by stabilizing the proper 3D-
folding of proteins. It assists in protein folding, and allows
the functional state of proteins to be maintained under
conditions, such as thermal stress, underwhich theywould
normally unfold and aggregate. This damage would
ultimately lead to apoptosis of the cell. HSP 70 also plays
a role in inducing the expression of other growth factors,
such as transforming growth factor (TGF)-beta, which is a
key element in the wound healing response and the
fibrogenic process. The dermal part of the MTZ itself is
free of any HSP 70 expression due to the absence of viable
cells in these areas, which confirms the results of theNBTC
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viability stain. Furthermore, there is an increase in the
HSP 70 expression in the tissue surrounding the dermal
MTZs (Fig. 6). This suggests sublethal damage to the
fibroblast and theproductionofHSP70 in theborder zoneof
the dermal MTZs, which then induces a wound healing
response in the dermis.
IHC staining for alpha smooth muscle actin detects
scattered myofibroblasts (Fig. 8), which corresponds to the
dermal wound healing response that is described by
Gabbiani et al. [15–18] These myofibroblasts are one of
the main forces behind the mechanism of wound contrac-
tion, and could induce additional skin tightening. We
hypothesize that MTZs that are created by FP induce a
woundhealing responsewith thedeposition of newcollagen
and an increase in dermal collagen remodeling. Further
studies with objective measurements of the dermal remo-
deling process after FP as carried out by Orringer et al. for
CO2 laser resurfacing are warranted.
The gold standard for skin rejuvenation is still ablative
resurfacing with CO2 or Er:YAG laser. The wound healing
response that is induced by ablative resurfacing is always
followed by the development of a variable degree of
superficial dermal fibrosis in the treated region [1].
Depending on the degree of this intradermal fibrosis, the
optical properties of the skin change. Ultimately these
changes can result in a cosmetically unpleasant porcelain
white hypopigmentation of the treated area, particularly in
light-skinned individuals, which leaves the patient with an
unnatural appearance. It still remains to be determined
whether some degree of fibrosis in the dermis is desirable to
create a cosmetically appealing result. In this histological
study, we did not find any evidence of dermal fibrosis
3 months after FP. Please note that these findings relate to
a single FP treatment. Serial treatments with FP may
induce dermal fibrosis, and further studies are, therefore,
warranted to observe the histological changes after serial
treatments with FP.
The increase in elastic fibers is an important contributor
to the findings on dermatoheliosis. Although collagen
denaturation is demonstrated inMTZs, there is no evidence
of a change in the morphology or the content of the elastic
fibers after FP (Fig. 5). These findings indicate that FPwith
the settings that were used in this study has no direct effect
on elastic fibers. As all of the biopsies were taken from the
UV-protected surface of the inner forearm, none of them
showed the elastin sheets that characterize solar elastosis.
Additional histological studies from UV-exposed areas are
needed to demonstrate the effects of FP on the altered
elastin that is present in solar elastosis. Future studies are
also needed to investigate whether modification of the
exposure parameters, such as an increase in energy per
MTZ, leads to a different effect on the elastic fibers.
Another important component of dermatoheliosis is the
formation of teleangiectasias. Interestingly, the emitted
wavelength in FP is not selectively absorbed by blood-
containing targets, and thus does not provide selective
photothermolysis to thebloodvessels.However, by creating
a multitude of zones of intense thermal damage in the
upper dermis, FP may non-selectively coagulate vessels in
the upper dermis (Fig. 2b). Therefore, segments of vessels
in the area of the MTZs are sealed, which compromises the
blood flow of the entire vessel. This histological finding
correlates very well with anecdotal reports of a decrease in
teleangiectasias after FP treatment. FP may, therefore,
offer a new method for targeting blood vessels when the
distribution of vessels and the thermal damage pattern are
well matched.
An especially troublesome side effect of ablative laser
resurfacing is the induction of postinflammatory hyperpig-
mentation (PIH). It is striking to see the marked localized
thermal damage that is induced by FP, which is associated
only with relatively mild inflammation. This may be
explained by the characteristic microscopic nature of the
damage pattern that is produced by FP, which leads to
minimal inflammation and thus a lower incidence of
clinically evident PIH. Although none of the subjects in
this study experienced clinically evident PIH, one biopsy
from a patient with Fitzpatrick skin type VI revealed a few
scattered dermal melanophages in the treatment area
3 months after FP. This is most likely to be a histological
equivalent to sub-clinical PIH. The absence of clinically
evident PIH in our study patients suggests a lower risk of
PIH development after FP compared to standard ablative
resurfacing. However, the presence ofmelanophages in the
dermis of one patient suggests that a possibility of
developing PIH after FP, especially in patients with darker
skin types, remains.
This study was performed with a prototype device that
delivers a very regular pattern of FP. The currently
commercially available devices (FraxelTM) applies the
MTZ pattern in multiple passes and deliver a statistically
randomized treatment pattern. This implies that the
distance between individual MTZs is not well defined,
although theaverageMTZdensity is defined.Furthermore,
an irregular pattern may be produced, which may ulti-
mately result in an alteration in the response of the
epidermis and the dermis to FP. A quantitative analysis
of the patterns and biological wound healing that is
achieved with commercially available devices requires
further study.
Future applications of FPmight involve the treatment of
Poikiloderma of Civatte by its ability to treat dyschromia
along with teleangiectasias; the treatment of melasma by
its ability to remove epidermal pigmentwith the help of the
‘‘Melanin Shuttle,’’ and the possible combination with
topical agents as a way to profit from synergistic effects of
laser and drug therapy.
CONCLUSION
FP induces a wound healing response in the dermis by
the creation of a new thermal damage pattern. The
epidermis recovers fast and apparently completely within
7 days after the treatment. The thermally damaged
collagen inside the MTZ is completely replaced with new
collagen within 3 months. No evidence of dermal fibrosis is
observed after a single FP treatment in this 3-month follow
up study. Additionally FP appears to randomly coagulate
small blood vessels in the papillary dermis.
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The precise removal of epidermal pigment is possible,
as the MENDs act as a melanin shuttle. The clinically
observed lightening of epidermal pigmentation is probably
secondary to the redistribution and partial release of
epidermal melanin as a result of MENDs migration.
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